Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 1;383(3):26.
doi: 10.1007/s41061-025-00509-9.

Recent Advances in Synthetic Strategies and Biological Properties of Indazole Scaffolds: A Review

Affiliations
Review

Recent Advances in Synthetic Strategies and Biological Properties of Indazole Scaffolds: A Review

S N Murthy Boddapati et al. Top Curr Chem (Cham). .

Abstract

Research on heterocyclic compounds is an area of continuous focus, capturing the interest of both synthetic and natural product chemists. Indazoles are one of the rare heterocycles that are available in nature. Indazole and its derivatives are one of the most important classes of heterocycles in pharmacological molecules. The structurally different indazole motifs, with impressive bioactivity, have drawn increasing attention from medicinal chemists in recent years for the continuous development of novel drug moieties. Thus, knowledge of the biological activities and synthetic pathways of indazole scaffolds is essential to enhancing further developments in the number of indazole-based lead molecules. The goal of the present review is to highlight information on the biological properties of some existing indazole-based drugs and activities of novel bioactive indazole compounds in clinical trails, with specific attention to the most recent advances in various synthetic strategies towards indazole and its derivatives over the past 7 years (2017-2024). Moreover, we discuss the substrate tolerance and mechanistic insights for most of the summarized synthetic protocols.

Keywords: Biological activities; Clinical trails; Heterocycles; Indazole; Mechanistic insights; Synthetic routes.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Tautomeric forms of indazoles
Fig. 2
Fig. 2
Significant bioactive indazole scaffolds
Fig. 3
Fig. 3
Bioactive indazole compounds in clinical trails
Scheme 1
Scheme 1
The first report of the creation of indazole
Scheme 2
Scheme 2
Previously reported techniques for the construction of indazoles [–75]
Scheme 3
Scheme 3
Synthesis of indazole scaffolds 3av
Scheme 4
Scheme 4
Substrate scope for the Rh(III)-promoted C–H activation of phthalazinones and allenes
Scheme 5
Scheme 5
Possible mechanism for indazole 3a formation
Scheme 6
Scheme 6
Synthesis of indazole N-oxides
Scheme 7
Scheme 7
Scope of sulfonium ylides for the construction of indazole N-oxides
Scheme 8
Scheme 8
Possible mechanism for the formation of inazole N-oxide
Scheme 9
Scheme 9
Construction of 2H-indazol-3-yl-methanolderivatives
Scheme 10
Scheme 10
Substrate scope for the generation of 2H-indazol-3-yl-methanol derivatives
Scheme 11
Scheme 11
Substrate scope for unsymmetrical 2H-indazol-3-yl-methanol scaffolds
Scheme 12
Scheme 12
Plausible mechanism of 2H-indazol-3-yl-methanol synthesis
Scheme 13
Scheme 13
Synthesis of CF3-tethered indazoles
Scheme 14
Scheme 14
Substrate scope for preparation of CF3-tethered indazoles
Scheme 15
Scheme 15
Scope of CF3-ynones
Scheme 16
Scheme 16
Plausible mechanism for CF3-tethered indazole 12a
Scheme 17
Scheme 17
Rh(III)-catalyzed synthesis of 3-acyl-2H-indazoles
Scheme 18
Scheme 18
Scope of symmetrical azobenzenes
Scheme 19
Scheme 19
Scope of unsymmetrical azobenzenes
Scheme 20
Scheme 20
Scope of sulfoxonium ylides
Scheme 21
Scheme 21
Plausible reaction mechanism for 3-acyl-2H-indazole16a
Scheme 22
Scheme 22
Pd-mediated construction of N-methyl-3-aryl indazoles
Scheme 23
Scheme 23
Synthesis of title compounds 21a–j
Scheme 24
Scheme 24
Ag(I)-catalyzed synthesis of 1,3-substituted indazoles
Scheme 25
Scheme 25
Substrate scope for 1,3-substituted indazole
Scheme 26
Scheme 26
Substrate scope for 1-aryl substituents
Scheme 27
Scheme 27
Plausible reaction mechanism 1,3-substituted indazole
Scheme 28
Scheme 28
Synthesis of 2-aryl-2H-indazole-3-phosphonates
Scheme 29
Scheme 29
Substrate scope for 2-aryl-2H-indazole-3-phosphonates
Scheme 30
Scheme 30
A possible mechanism for the construction of 2-aryl-2H-indazole-3-phosphonates
Scheme 31
Scheme 31
Construction of tetraaryl indazoles using Pd catalyst
Scheme 32
Scheme 32
Substrate scope for the synthesis of tetraaryl indazoles
Scheme 33
Scheme 33
Construction of substituted 1H-indazoles using Cu catalyst
Scheme 34
Scheme 34
Synthesis of substituted 1H-indazoles 33a–k
Scheme 35
Scheme 35
A possible mechanism for substituted 1H-indazoles 33a
Scheme 36
Scheme 36
Synthetic route for indazole carboxylic acids
Scheme 37
Scheme 37
Synthesis of E-hydrazone esters 35a–h
Scheme 38
Scheme 38
Substrate scope for indazole carboxylic acids
Scheme 39
Scheme 39
Synthetic path for 2-aryl-2H-indazoles
Fig. 4
Fig. 4
Synthetic route for Cu(I) complexes
Scheme 40
Scheme 40
Synthesis of 2-aryl-2H-indazoles 39a–o
Scheme 41
Scheme 41
Possible mechanism for 2-aryl-2H-indazole formation
Scheme 42
Scheme 42
Synthetic route for 2-aryl-2H-indazoles 42a–l
Scheme 43
Scheme 43
Synthesis of 2-aryl-2H-indazoles 42a–l
Scheme 44
Scheme 44
Plausible mechanism for construction of 2-phenyl-2H-indazole 42a
Scheme 45
Scheme 45
One-pot synthesis of N-phenyl-1H-indazoles
Scheme 46
Scheme 46
Substrate scope for N-phenyl-1H-indazoles
Scheme 47
Scheme 47
Substrate scope forN-thiazolyl-1H-indazoles
Scheme 48
Scheme 48
Route for the synthesis of fluorinated indazoles
Scheme 49
Scheme 49
Substrate scope for fluorinated indazoles. a Chromatographicisolated yields; compounds 49e and 49f are purchased commercially available materials
Scheme 50
Scheme 50
Presumptive Ullmann mechanism for fluorinated indazole (51)
Scheme 51
Scheme 51
Cu-mediated construction of 3-aryl-1H-indazoles
Scheme 52
Scheme 52
Substrate scope for 3-aryl-1H-indazoles
Scheme 53
Scheme 53
Possible mechanism for 3-phenyl indazole 53a
Scheme 54
Scheme 54
Cu(OAc)2 promoted construction of 1N-alkoxycarbonyl indazoles
Scheme 55
Scheme 55
Scope of boronic acids 54 in the reaction with diazadicarboxylate tert-butyl-2-acetylhydrazine-1-carboxylate (55)
Scheme 56
Scheme 56
Scope of boronic acid 54 in the reaction with diisopropyl (E)-diazene-1,2-dicarboxylate(57)
Scheme 57
Scheme 57
Proposed mechanism for 1N-alkoxycarbonyl indazole
Scheme 58
Scheme 58
Base-catalyzed cyclization of 2-nitrobenzylamines
Scheme 59
Scheme 59
Microwave-assisted synthesis of hydroxy- and alkoxyindazole acetic acids (60a–h)
Scheme 60.
Scheme 60.
Plausible mechanism for alkoxyindazole acetic acid 60a
Scheme 61
Scheme 61
Synthetic route for bis-indazoles
Scheme 62
Scheme 62
Substrate scope of the one-pot sequential cascade reaction of annulated bis-indazoles
Scheme 63
Scheme 63
Substrate scope of the one-pot sequential cascade reaction of annulated indazoles
Scheme 64
Scheme 64
Proposed mechanism for the one-pot sequential cascade reaction
Scheme 65
Scheme 65
Synthesis of indazole using conventional and ultrasound sonication method using H3PMo12O40 and H3PW12O40
Scheme 66
Scheme 66
Ultrasound method for preparation of indazole derivatives (68a–f) by using H3PMo12O40
Scheme 67
Scheme 67
Ultrasound method for preparation of indazole derivatives 63g–l by using H3PW12O40
Scheme 68
Scheme 68
Possible mechanism using H3PMo12O40 and H3PW12O40 for synthesis of 68a–l
Scheme 69
Scheme 69
Ultrasound-assisted synthesis of 2-phenyl-2H-indazole derivatives
Scheme 70
Scheme 70
Substrate scope for 2-phenyl-2H-indazoles 71a-l.a The reaction mixture was ultrasonicated for four cycles for 1 h at 40 °C
Scheme 71
Scheme 71
Ultrasonic-promoted synthesis of 2-aryl indazoles75a–o
Scheme 72
Scheme 72
A plausible mechanism for the construction of 2-phenyl-2H-indazole 75a
Scheme 73
Scheme 73
Metal-free synthesis of 2H-indazoles in photochemical/thermal conditions
Scheme 74
Scheme 74
Synthesis of N,N-diethyl-3-(sufonyl)-2H-indazol-2-amines
Scheme 75
Scheme 75
Synthesis of 2H-indazole-3-carbaldehydes
Scheme 76
Scheme 76
Plausible mechanism for 3-((arylsulfonyl)methyl)-N,N-diethyl-2H-indazol-2-amine
Scheme 77
Scheme 77
Possible mechanism2-(diethylamino)-2H-indazole-3-carbaldehyde 79a
Scheme 78
Scheme 78
Synthetic route for 3-alkyl/aryl-3H-indazole-3-phosphonates and 3-alkyl/aryl-1H-indazoles
Scheme 79
Scheme 79
Substrate scope for 3-alkyl/aryl-3H-indazole-3-phosphonates and 3-alkyl/aryl-1H-indazoles
Scheme 80
Scheme 80
Plausible mechanism for 3-alkyl/aryl-3H-indazole-3-phosphonate (82) and 3-alkyl/aryl-1H-indazole (83)
Scheme 81
Scheme 81
Synthesis of indazoles 85a–l by diazo activation strategy
Scheme 82
Scheme 82
Substrate scope for methyl 1-(aryl)-1H-indazole-3-carboxylate
Scheme 83
Scheme 83
Diazo activation by diazonium and formation of diazenium intermediate
Scheme 84
Scheme 84
Cadogan synthesis of 2-aryl indazoles
Scheme 85
Scheme 85
Potassium methoxide-promoted synthesis of 2-aryl-2H-indazoles
Scheme 86
Scheme 86
Substrate scope for 2-aryl-2H-indazoles
Scheme 87
Scheme 87
Plausible mechanism for 2-phenyl-2H-indazole 89a
Scheme 88
Scheme 88
Reaction pathway for the synthesis of indazole derivatives 1a–d and 2a–d
Scheme 89
Scheme 89
Indazole derivatives 94a–d and 95a–d
Scheme 90
Scheme 90
Reaction path for the synthesis of different 1,3-substituted 1H-indazoles
Scheme 91
Scheme 91
Synthesis of N,1-diaryl-1H-indazol-3-amines
Scheme 92
Scheme 92
Possible mechanism for 1-phenyl-1H-indazol-3-amine (98a)
Scheme 93
Scheme 93
Synthetic pathway for 3-methyl-1-phenyl-1H-indazole motifs (102a–c)

Similar articles

References

    1. Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB (2020) A Review on recent advances in nitrogen containing molecules and their biological applications. Molecules 10.3390/molecules25081909 - PMC - PubMed
    1. Aaron DM, Musa ZN, Makhluf JH, Mark JK (2006) N,N-bond-forming heterocyclization: synthesis of 3-alkoxy-2H-indazoles. J Org Chem. 10.1021/jo0524831 - PubMed
    1. Thangadurai A, Minu M, Wakode S, Agarwal S, Narasimhan B (2012) Indazole: a medicinally important heterocyclic moiety. Med Chem Res. 10.1007/s00044-011-9631-3
    1. Büchel GE, Stepanenko IN, Hejl M et al (2012) Osmium (IV) complexes with 1H-and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity. J Inorg Biochem. 10.1016/j.jinorgbio.2012.04.001 - PMC - PubMed
    1. Catalan J, Elguero J (1987) Basicity and acidity of azoles. Adv Heterocyclic Chem. 10.1016/s0065-2725(08)60162-2

LinkOut - more resources